 |
|
|
| |
EFFECT OF FALDAPREVIR ON RALTEGRAVIR PHARMACOKINETICS IN HEALTHY VOLUNTEERS
|
| |
| |
Reported by Jules Levin
CROI 201 March 3-6 Boston, MA
David Joseph1, Peter Rose2, Natalja Strelkowa2, Armin Schultz3, Jeanette Garcia1, Mabrouk Elgadi4, Anne-Marie Quinson1, Fenglei Huang1
1Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; 3CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany; 4Boehringer Ingelheim Ltd, Burlington, ON, Canada
|
| |
|
|
|
|
|
